Basal media required for growth of Endothelial cells, Phenol Red Free, 500 mL (supplements and growth factors sold separately)
Human Peripheral Blood CD14+ Monocytes, Cryopreserved, Negative Selection, 10 million
Cryopreserved ampule of Human Peripheral Blood CD14+ Monocytes, negative selection, containing ≥10 million cells
Cryopreserved ampule of negatively selected Human Peripheral Blood CD14+ Monocytes, containing ≥ 50 million cells
Culture system containing EBMTM Basal Medium (CC-3121) and EGMTM Endothelial Cell Growth Medium SingleQuotsTM Supplements (CC-4133) required for growth of endothelial cells. (Pack of 6)
Culture system containing EBMTM-2 Basal Medium (CC-3156) and EGMTM-2 MV Microvascular Endothelial Cell Growth Medium SingleQuotsTM supplements (CC-4147) required for growth of Microvascular Endothelial Cells (Pack of 6)
This product has been discontinued. The suggested alternative is EGMTM-2 MV Microvascular Endothelial Cell Growth Medium-2 BulletKitTTM (Catalog # CC-3202) and/or its components.
This product has been discontinued. The suggested alternative is EGMTM-2 MV Microvascular Endothelial Cell Growth Medium-2 BulletKitTM (Cat. # CC-3202) and/or its components.
Culture system containing EBMTM-2 Basal Medium (CC-3156) and EGMTM-2 SingleQuotsTM Supplements (CC-4176) required for growth of Endothelial Cells. Available for immediate shipment.
This product has been discontinued. The suggested alternative is EGMTM-2 MV Microvascular Endothelial Cell Growth Medium-2 BulletKitTTM (Catalog # CC-3202) and/or its components.
-
Inducible Cas9 T Cells: An Innovative Platform for Allogeneic CAR-T Cell GenerationPoster on inducible Cas9 T Cells
-
Synthego_Lonza_Protocol_Genome Editing of Resting T cellsTechnical Protocol on Genome Editing of Resting T cells for associated White Paper "Genome Editing of Resting T cells"
-
CAR T cells in Cancer TherapyA poster developed by Nature Reviews in conjunction with Lonza to present CAR T cells in cancer therapy. This poster demonstrates the recognition of tumor peptides by T cells, CAR T cell manufacturing, the types of chimeric antigen receptors and a timeline of CAR development over more than 30 years.
-
PBMC Based T Cell Proliferation AssayProtocol instructions
-
Instructions for Use – TheraPEAK® T-VIVO® Cell Culture Medium for Gamma Delta (γδ) T CellsInstructions for how to culture gamma delta (γδ) T Cells using TheraPEAK® T-VIVO® Cell Culture Medium
-
Instructions for Use - Dendritic Cell (DC) and T Cell Assay from Matched PBMCsProtocol for DC and T Cell Assay from Matched PBMCs
-
Case Study – Improving the Expansion of Patients' T CellsIn this serum-free media case study, learn how selection of memory T cells can aid in streamlining CAR-T therapies.
-
Synthego-Lonza Genome Editing of Resting T cellsCase Study on Genome Editing of Resting T cells
-
cGMP Kit T Optimization Protocol - Nucleofector™ 1/2 Device SeriescGMP Cell Line Nucleofector Kit T
-
CAR-T Cells – Latest Advances and Outstanding Challenges